Navigation Links
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Date:1/24/2008

Amoxicillin PULSYS to be Marketed as MOXATAG(TM) - First Once-Daily

Amoxicillin Product Approved in U.S.

GERMANTOWN, Md., Jan. 24 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that it has received approval of its New Drug Application (NDA) from the U.S. Food and Drug Administration (FDA), for its once-daily MOXATAG(TM) Tablets 775 mg (amoxicillin extended-release tablets) for the treatment of adults and pediatric patients 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes (commonly referred to as strep throat).

The FDA approval was based on results from a Phase 3 clinical study conducted with more than 600 patients that found once-daily MOXATAG for 10 days was effective in eradicating bacteria responsible for strep throat and demonstrated statistical non-inferiority to a four times daily dose of penicillin for 10 days. MOXATAG was very well tolerated in the clinical trial.

"We are extremely gratified to have received FDA approval of our MOXATAG NDA," stated Edward Rudnic, Ph.D., president and CEO of MiddleBrook. "As the first and only once-daily amoxicillin therapy approved for marketing in the United States, we believe MOXATAG represents a major advance for patients and doctors seeking safe, effective, and convenient treatment options for strep throat. We now look forward to continuing our ongoing strategic evaluation process from a position of greater strength with this approval in hand."

In accordance with the requirements of the Pediatric Research Equity Act, MiddleBrook has agreed with the FDA to further
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
2. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Tess...croarray-based applications, announces the launch ...sting of the mutations that underlie human heredit...tise in microarray-based resequencing with novel n...ysis software enables screening for all targeted m...
(Date:11/9/2009)..., PALO ALTO, Calif., Nov. 9 Women... it has changed its name to Viveve as it prepares ...in select U.S. markets. ,, "Viveve is a name th...focus on women,s sexual health," said Kerry Pope, ...ists for the sole purpose of helping women restore...
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
(Date:11/9/2009)...why this is so, however , , MONDAY, No... with very dense breasts have a higher risk of can... shows. , Breast density has already been linke...er, and experts have suspected that very dense bre... of cancer recurrence at the site of the original ...
(Date:11/9/2009)...wire-USNewswire/ -- Speaker Nancy Pelosi released...e Affordable Health Care for America Act (H.R....duce Medicare Part D costs for people living with ...y a vote of 220 to 215: ,, "Effective drug tre...ife for thousands of Americans living with HIV/AID...
(Date:11/9/2009)...PRNewswire/ -- Abt Associates continues to broad...ergency management consulting and support services...the work of the Federal Emergency Management Agenc...onal Commission on Children and Disasters and the ...ATA). The value of the combined contracts is appr...
(Date:11/9/2009)...mental Procedure for Preteen Son - ,, PHILADE...ts of children with cancer, the hopeful news is th... for decades. Among the bad news -- treatments tha... Boys diagnosed with cancer who have reached puber... fertility: before undergoing cancer treatment, th...
(Date:11/9/2009)...wire-USNewswire/ -- The American Academy of Physic...00 clinically practicing physician assistants (PAs...S. House of Representatives for passing Saturday i...ble Health Care for America Act. ,, "We are esp...ately lower the cost of health care and greatly ex...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
...hildren that jumping for joy can hurt them, accord...ship Children's Hospital, Auckland, have called fo...rising number of children being injured while jump...ncrease in pre-Christmas trampoline sales, compare...
...bviously a difficult question to answer. //There i...ving stem cell research that this is a fast growin... medicine. Ideally a properly funded nation... to us because that is not an option for them: the...
... dietary regime which will include lots of green v...amount of calcium. This type of food guide is the ...od Guide has addressed this guide to all the Canad...rescribed by the Food Guide may affect the sale of...
...ng blood loss in patients undergoing cardiac surge...during five years following// the surgery, accordi...ed for use in high-risk patients needing coronary ...ave received aprotinin since 1985, principally dur...
...ive compounds that stimulate white blood cell prod...herapy are at an increased// risk of developing a ...stic syndrome, according to a new study in the Feb...be taken into consideration when making treatment ...
...es Network (SIGN) has published a set of guideline...00 cardiovascular complaints// like heart attacks ... aims to provide preventive treatment to about 500...ms to provide lifestyle advice. As per the g...
Other Medicine News:Health News:Drug Used in Coronary Artery Bypass Surgery may Increase Risk of Death 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 3Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
L-Hook Electrode
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
Medicine Products: